天美影院

Woman with an illustration of a blood clot

Diagnose von Willebrand disease using GPIbM technology

Features & Benefits

To correctly diagnose cases involving a bleeding anamnesis or a family history of von Willebrand disease and subsequently monitor patient response to therapy, physicians require a specific test for von Willebrand factor (VWF). A functional assay is the preferred screening method for detecting quantitative as well as qualitative defects of von Willebrand factor.1

Now available for U.S. labs, the INNOVANCE庐 VWF Ac assay uses the guideline recommended VWF: GPIbM technology, allowing for a more accurate functional assessment of VWF with greater precision and heightened sensitivity. The GPIbM technology mimics true VWF function and detects variants missed by other assay technologies.


  • INNOVANCE VWF Ac assay uses recombinant GPIb with 2 gain of function mutations in a latex based GPIb-binding assay
  • GPIb spontaneously binds to native VWF
  • Ristocetin is not needed

1
Subscription Button Icon
Be the first to know about our events, training, and news